For the Inventor, By the Inventor

Enter assignee name

Bellevue, WA, United States of America

Systimmune, Inc.

USPTO Granted Patents = 15

EPO Patents = 4

Forward Citations = 6

Loading Chart...

Loading Chart...

36 inventors (with patents filed for the assignee):

Yi Zhu (15 out of 22 patents)

Brian Robert Kovacevich (11 out of 67 patents)

Zeren Gao (10 out of 52 patents)

4. Blair R Renshaw (10 out of 20 patents)

5. Dong Xia (9 out of 13 patents)

6. Ole Olsen (8 out of 35 patents)

7. David Jellyman (8 out of 9 patents)

8. Bill Brady (8 out of 9 patents)

9. Shi Zhuo (6 out of 8 patents)

10. Katrina Bykova (6 out of 8 patents)

11. Anne-Marie K Rousseau (6 out of 6 patents)

12. Phil Tan (5 out of 7 patents)

13. Yu Liang (5 out of 5 patents)

14. Jeffrey B Adamo (3 out of 4 patents)

15. Lan Chen (2 out of 3 patents)

15 patents: Sort by Forward Citations

1. 12735487 - MULTI-SPECIFIC ANTIBODIES AND METHODS OF MAKING AND USING THEREOF (2026-09-15),

2. 12709647 - MULTI-SPECIFIC ANTIBODIES AND METHODS OF USING THEREOF (2026-08-18),

3. 12605458 - Antibody-drug conjugate having acidic self-stabilization junction (2026-04-21),

4. 12577325 - BISPECIFIC ANTIBODY-CAMPTOTHECIN DRUG CONJUGATE AND PHARMACEUTICAL USE THEREOF (2026-03-17),

5. 12577319 - Anti-trop2 Antibody (2026-03-17),

6. 12428483 - Bispecific tetravalent antibodies and methods of making and using thereof (2025-09-30),

7. 12384850 - Guidance and navigation control proteins and method of making and using thereof (2025-08-12),

8. 12268752 - Non-natural amatoxin-type antibody conjugate (2025-04-08),

9. 12029761 - Guidance and Navigation Control proteins and method of making and using thereof (2024-07-09),

10. 11787863 - Multi-specific antibodies and methods of making and using thereof (2023-10-17),

11. 11649286 - Tri-specific antibodies (2023-05-16),

12. 11535667 - Anti-CD3 antibodies and methods of making and using thereof (2022-12-27),

13. 11518815 - Anti-ROR1 antibodies and methods of making and using thereof (2022-12-06),

14. 11466084 - Anti-PD-1 antibodies and methods of making and using thereof (2022-10-11),

15. 10919977 - Bispecific tetravalent antibodies and methods of making and using thereof (2021-02-16),

Systimmune, Inc. is a biopharmaceutical company focused on the discovery and development of novel therapies for cancer and autoimmune diseases. With their innovative technologies and deep expertise in immunology, Systimmune is dedicated to transforming the treatment landscape for patients in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

15 Patents

#43 in Bellevue, WA

#457 in Washington

#21,026 in US

#39,846 in the World

Bellevue, WA, United States of America

Systimmune, Inc.

Forward Citations = 6

36 inventors:

Yi Zhu (15 out of 22 patents)

Brian Robert Kovacevich (11 out of 67 patents)

Zeren Gao (10 out of 52 patents)

4. Blair R Renshaw (10 out of 20 patents)

5. Dong Xia (9 out of 13 patents)

Please report any incorrect information to [email protected]

Loading…